Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 2
1967 1
1968 2
1971 2
1976 2
1977 1
1979 1
1980 3
1981 3
1982 5
1983 4
1984 6
1985 3
1986 6
1987 6
1988 7
1989 16
1990 13
1991 18
1992 10
1993 20
1994 24
1995 14
1996 29
1997 23
1998 18
1999 24
2000 21
2001 29
2002 31
2003 47
2004 50
2005 73
2006 77
2007 94
2008 125
2009 141
2010 130
2011 158
2012 161
2013 208
2014 215
2015 309
2016 325
2017 352
2018 417
2019 506
2020 573
2021 631
2022 797
2023 737
2024 874
2025 340

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,872 results

Results by year

Filters applied: . Clear all
Page 1
Glutamate acts on acid-sensing ion channels to worsen ischaemic brain injury.
Lai K, Pritišanac I, Liu ZQ, Liu HW, Gong LN, Li MX, Lu JF, Qi X, Xu TL, Forman-Kay J, Shi HB, Wang LY, Yin SK. Lai K, et al. Among authors: yin sk. Nature. 2024 Jul;631(8022):826-834. doi: 10.1038/s41586-024-07684-7. Epub 2024 Jul 10. Nature. 2024. PMID: 38987597 Free PMC article.
Characterizing Long COVID in Children and Adolescents.
Gross RS, Thaweethai T, Kleinman LC, Snowden JN, Rosenzweig EB, Milner JD, Tantisira KG, Rhee KE, Jernigan TL, Kinser PA, Salisbury AL, Warburton D, Mohandas S, Wood JC, Newburger JW, Truong DT, Flaherman VJ, Metz TD, Karlson EW, Chibnik LB, Pant DB, Krishnamoorthy A, Gallagher R, Lamendola-Essel MF, Hasson DC, Katz SD, Yin S, Dreyer BP, Carmilani M, Coombs K, Fitzgerald ML, Güthe N, Hornig M, Letts RJ, Peddie AK, Taylor BD, Balaraman V, Bogie A, Bukulmez H, Dozor AJ, Eckrich D, Elliott AJ, Evans DN, Farkas JS, Faustino EVS, Fischer L, Gaur S, Harahsheh AS, Hasan UN, Hsia DS, Huerta-Montañez G, Hummel KD, Kadish MP, Kaelber DC, Krishnan S, Kosut JS, Larrabee J, Lim PPC, Michelow IC, Oliveira CR, Raissy H, Rosario-Pabon Z, Ross JL, Sato AI, Stevenson MD, Talavera-Barber MM, Teufel RJ, Weakley KE, Zimmerman E, Bind MC, Chan J, Guan Z, Morse RE, Reeder HT, Akshoomoff N, Aschner JL, Bhattacharjee R, Cottrell LA, Cowan K, D'Sa VA, Fiks AG, Gennaro ML, Irby K, Khare M, Guttierrez JL, McCulloh RJ, Narang S, Ness-Cochinwala M, Nolan S, Palumbo P, Ryu J, Salazar JC, Selvarangan R, Stein CR, Werzberger A, Zempsky WT, Aupperle R, Baker FC, Banich MT, Barch DM, Baskin-Sommers A, Bjork … See abstract for full author list ➔ Gross RS, et al. Among authors: yin s. JAMA. 2024 Aug 21;332(14):1174-88. doi: 10.1001/jama.2024.12747. Online ahead of print. JAMA. 2024. PMID: 39196964 Free PMC article.
Global, regional, and national prevalence of hearing loss from 1990 to 2019: A trend and health inequality analyses based on the Global Burden of Disease Study 2019.
Jiang CY, Han K, Yang F, Yin SY, Zhang L, Liang BY, Wang TB, Jiang T, Chen YR, Shi TY, Liu YC, Chen SW, Tong BS, Liu YH, Pan HF, Han YX. Jiang CY, et al. Among authors: yin sy. Ageing Res Rev. 2023 Dec;92:102124. doi: 10.1016/j.arr.2023.102124. Epub 2023 Nov 14. Ageing Res Rev. 2023. PMID: 37972859 Free article.
Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study.
Budde LE, Assouline S, Sehn LH, Schuster SJ, Yoon SS, Yoon DH, Matasar MJ, Bosch F, Kim WS, Nastoupil LJ, Flinn IW, Shadman M, Diefenbach C, O'Hear C, Huang H, Kwan A, Li CC, Piccione EC, Wei MC, Yin S, Bartlett NL. Budde LE, et al. Among authors: yin s. J Clin Oncol. 2022 Feb 10;40(5):481-491. doi: 10.1200/JCO.21.00931. Epub 2021 Dec 16. J Clin Oncol. 2022. PMID: 34914545 Free PMC article. Clinical Trial.
Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study.
Budde LE, Assouline S, Sehn LH, Schuster SJ, Yoon SS, Yoon DH, Matasar MJ, Bosch F, Kim WS, Nastoupil LJ, Flinn IW, Shadman M, Diefenbach C, Cheah CY, Ma CY, Huang H, Kwan A, Wei MC, Yin S, Bartlett NL. Budde LE, et al. Among authors: yin s. J Clin Oncol. 2024 Jul 1;42(19):2250-2256. doi: 10.1200/JCO.23.02329. Epub 2024 Mar 28. J Clin Oncol. 2024. PMID: 38547425 Free PMC article. Clinical Trial.
6,872 results